R-7103

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameR-7103
Drug Alias NameR-7103RG-7103RO-5024118
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVasoactive intestinal polypeptide receptor 2 agonists
TargetsVasoactive intestinal polypeptide receptor 2
Therapy Area/IndicationsPulmonary Disease, Chronic Obstructive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesF. Hoffmann-La Roche Ltd
Active IndicationsN/A
Inactive IndicationsPulmonary Disease, Chronic Obstructive

Other Information

ATC CodeN/A
Related LinksN/A